SIRT3 also exerts tumor-suppressive effects through activation by PGC-1α, which enhances oxidative phosphorylation while inhibiting glycolysis and cellular proliferation, an activity correlated with improved patient survival [137]. The gene discussed is SIRT3; the disease is neoplasm.